When a vaccine designed to protect girls against a sexually transmitted virus arrived three years ago, the debate centered on redone question: Would the shots make young girls more likely to have sex?

Now the vaccine's maker is trying to get approval to sell the vaccine for boys, and the debate is focusing on something else entirely: Is it worth the money, and is it safe and effective enough?

Shocking that the concern for young men isn't about promiscuity.

(from feministing.com)